2019 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Total number of projects: 5
As coordinator: 0
As participant: 5
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2022 | 0 | 25.935.660 | 766.707 | 3 | ||
2019 | 0 | 1.257.271 | 1.875 | 2 |
Total number of partners: 54
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 54
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2022-09-01 | Metabolic imprinting of Th17 cells in disease pathogenesis | Th17 tissue metab | participant | 265.648 | 2 |
2022-09-01 | Precision drug REPurpOsing For EUrope and the world | REPO4EU | participant | 22.982.612 | 28 |
2022-09-01 | Training the next-generation of European GLIOblastoma (translational) researchers, to RESOLVE precision targeting of the brain tumour microenvironment | GLIORESOLVE | participant | 2.687.400 | 21 |
2019-07-01 | To develop 3D bioPRINTed osteoinductive constructs that deliver CHEMOtherapeutics within large bone defects that are surgically created when removing bone tumours. | PRINT-CHEMO | participant | 257.561 | 2 |
2019-05-01 | Saracatinib Trial tO Prevent FOP | STOPFOP | participant | 999.710 | 6 |